RAP charting, page-79

I spoke to the Directors at Techknow conference a few weeks ago.

They expect t0 have $20 mil in revenues by the end of 2017. They are already having heaps of conversations with parties interested in entering commercial contracts but the Directors want to maximise revenues to RAP and hence they will start to enter commercial deals after the pre FDA meeting which they think will be a major share price catalyst. The pre fda meeting is next month.

Cheers